Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.

L C Rall1, R Roubenoff

  • 1Epidemiology Research Center, ML-2, Marshfield Clinic Research Foundation, 1000 N. Oak Avenue, Marshfield, WI 54449, USA. rall.laura@mcrf.mfldclin.edu

Rheumatology (Oxford, England)
|August 5, 2004
PubMed
Summary

Rheumatoid cachexia, a loss of body cell mass in rheumatoid arthritis (RA) patients, involves altered metabolism and inflammation. This review explores its mechanisms and potential interventions for RA patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Pharmacotherapies for the Treatment of Sarcopenia.

The Journal of frailty & aging·2019
Same author

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2018
Same author

Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2016
Same author

PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.

The Journal of frailty & aging·2015
Same author

Cardiometabolic risks during anabolic hormone supplementation in older men.

Obesity (Silver Spring, Md.)·2013
Same author

Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).

The journal of nutrition, health & aging·2011

Area of Science:

  • Rheumatology
  • Metabolic Medicine
  • Immunology

Background:

  • Rheumatoid arthritis (RA) can lead to 'rheumatoid cachexia,' characterized by loss of body cell mass (BCM).
  • This condition involves altered energy and protein metabolism, alongside increased inflammatory cytokine production (e.g., IL-1β, TNF-α).
  • Metabolic changes resemble aging but differ in etiology within RA.

Purpose of the Study:

  • To describe the metabolic abnormalities in rheumatoid cachexia.
  • To identify potential mechanisms driving BCM loss in RA patients.
  • To discuss potential intervention strategies for rheumatoid cachexia.

Main Methods:

  • Review of existing literature on rheumatoid cachexia.
  • Analysis of metabolic and inflammatory markers in RA patients.

Related Experiment Videos

  • Comparison of rheumatoid cachexia with aging-related metabolic changes.

    • Main Results:

    • Rheumatoid cachexia is defined by reduced total energy expenditure, increased resting energy expenditure, and increased protein catabolism.
    • Elevated inflammatory cytokines (IL-1β, TNF-α) are consistently observed.
    • Patients often have adequate caloric/protein intake but reduced physical activity.

    Conclusions:

    • Rheumatoid cachexia presents unique metabolic challenges in RA patients.
    • Understanding the distinct mechanisms is crucial for developing targeted interventions.
    • Further research into intervention strategies is warranted to manage BCM loss in RA.